Recent studies have shown that gut microbiome signatures associated with age and metabolism play a role in modulating cardiovascular disease risk. Researchers found that younger gut microbial age can counteract the risk of CVD linked to metabolic dysfunction. Gut microbial genomes from China and Japan have revealed insights into probiotic effects, cardiometabolic influences, and connections to diets, populations, and diseases.
Gut microbiome and metabolome profiling in Framingham heart study reveals cholesterol-metabolizing bacteria. Research from @TheXavierLab, published in @CellCellPress #ASMicrobe https://t.co/OhyVh8MPKE
Divergent age-associated and metabolism-associated gut microbiome signatures modulate cardiovascular disease risk https://t.co/D9WIYuzf4K
A study in @NatureMedicine shows that a signature of microbiome age modulates the risk of cardiovascular disease in metabolically unhealthy individuals. π https://t.co/6cMztEpaFR https://t.co/VIehUUYBmI
Prokaryotic and viral genomes recovered from 787 Japanese gut metagenomes revealed microbial features linked to diets, populations, and diseases. Read the full article in @CellGenomics #ASMicrobe https://t.co/49lNmbhpEk
Gut microbial genomes with paired isolates from China illustrate probiotic and cardiometabolic effects. Jiangnan University's Qixiao Zhai & colleagues report in @CellGenomics #ASMicrobe https://t.co/e3XaJvNAPl
Some age-associated and metabolism-associated gut microbiome signatures modulate cardiovascular disease risk. Scientists found younger gut microbial age appears to counteract the CVD risk attributable to metabolic dysfunction: https://t.co/YpC9NXef1p